GMD Commentary: Saturday, October 7, 2017

The GMD Commentary for Saturday, October 7, 2017

Last Saturday I featured four stocks, Micron Technology (MU), Puma Biotech (PBYI), Blueprint Medicines (BPMC) and Exelixis, Inc. (EXEL).  All were in biotechnology.   The biggest gainer was EXEL which jumped 6.11%.  MU and PBYI rose 0.86% and 1.38% respectively on the week.  The only loser this week was BPMC which slipped 4.89%.

In comparison, the DJIA, the Nasdaq and the S&P 500 were up 1.65%, 1.45% and 1.19%.  Meanwhile, the Nikkei rose 1.64%, the Shanghai was flat, the Hang Seng jumped 3.28% (!), Dax gained 0.99% and the FTSE rose 2.04%.

Oil resumed its decline this week, after rallying for the previous three or four weeks.  Energy and energy service companies followed gold down.

And this was the fourth week in a row that gold has fallen.  That is one that I do not understand.  With all of the turmoil in the world, and with the Federal budget deficit soaring, I do not understand why gold has not done better.  But it hasn’t.  And naturally the mining stocks have suffered as well, although several mining stocks did recover somewhat this week.

For this coming week I am going to feature four stocks again.  First, I am going to leave Exelixis (EXEL) on the list.  Then I am going to add Alnylam Pharmaceuticals, Inc. (ALNY).  Both of these first two are #biotechnology companies.  I am adding Visa Inc. (V) and DXC Technology Company (DXC) to the list.

Let’s make some money this week.  Let me know how the weekly list is working for you.

Remember to DYOD.  Do your own due diligence.

Special Note: The Disclaimers and Disclosures are an essential part of this Commentary.  Be sure to read Disclaimers and Disclosures which are linked here.

And be sure to visit The Global Macro Digest ® Main Page for many articles that I hope you find interesting.